Other
Payments Of Merger Related Costs Financing Activities
Zimmer Biomet Holdings Payments Of Merger Related Costs Financing Activities decreased by 100.0% to $0.00 in Q1 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.50M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2025May 5, 2025
How to read this metric
An increase indicates active M&A activity or significant costs associated with securing acquisition financing.
Detailed definition
Cash outflows specifically categorized as financing activities related to the costs of executing mergers, acquisitions,...
Peer comparison
Varies significantly based on the company's M&A strategy and deal frequency.
Metric ID:
other_payments_of_merger_related_costs_financing_activitiesHistorical Data
7 periods
| Q4 '21 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $45.00M | $0.00 | $4.00M | $1.50M | $6.30M | $1.00M | $0.00 |
| QoQ Change | — | -100.0% | — | -62.5% | +320.0% | -84.1% | -100.0% |
| YoY Change | — | — | — | — | +57.5% | — | -100.0% |
Range$0.00 – $45.00M
CAGR-100.0%
Avg YoY Growth-21.3%
Median YoY Growth-21.3%
Current Streak2 quarters decline
Payments Of Merger Related Costs Financing Activities at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's payments of merger related costs financing activities?
- Zimmer Biomet Holdings (ZBH) reported payments of merger related costs financing activities of $0.00 in Q1 2025.
- How has Zimmer Biomet Holdings's payments of merger related costs financing activities changed year-over-year?
- Zimmer Biomet Holdings's payments of merger related costs financing activities decreased by 100.0% year-over-year, from $1.50M to $0.00.
- What does payments of merger related costs financing activities mean?
- Cash spent on financing-related fees for mergers and acquisitions.